|
|
|
|
Prescription and Over-the-Counter Drug Product List: 12/2003
ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; BUTALBITAL; CAFFEINE TABLET; ORAL BUTALBITAL, ACETAMINOPHEN AND CAFFEINE >A> + MIKART 750MG;50MG;40MG N40496 001 DEC 23, 2003 DEC NEWA ACETAMINOPHEN; PROPOXYPHENE NAPSYLATE TABLET; ORAL DARVOCET A500 >D> + AAIPHARMA 500MG;100MG N76429 001 SEP 10, 2003 DEC CTNA >A> + 500MG;100MG N76429 001 SEP 10, 2003 DEC CTNA...
|
|
|
http://www.fda.gov/cder/orange/appendix_a.txt
400, ERYTHROMYCIN ETHYLSUCCINATE E.E.S., ERYTHROMYCIN ETHYLSUCCINATE EC-NAPROSYN, NAPROXEN ECONAZOLE NITRATE, ECONAZOLE NITRATE ECONOCHLOR, CHLORAMPHENICOL ECONOPRED PLUS, PREDNISOLONE ACETATE ECONOPRED, PREDNISOLONE ACETATE EDECRIN, ETHACRYNATE SODIUM EDECRIN, ETHACRYNIC ACID EDETATE DISODIUM, EDETATE DISODIUM EDEX, ALPROSTADIL EDROPHONIUM CHLORIDE PRESERVATIVE FREE, EDROPHONIUM...
|
|
|
ANDA Approvals - December 2003
- FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER - Search - -Approvals - December 2003 - ANDA Number Generic Drug Name Applicant Approval Date 1 65-161 AMOXICILLIN AND CLAVULANATE POTASSIUM TABLETS USP (CHEWABLE) 200 MG/28.5 MG (BASE) AND 400 MG/57 MG (BASE) - RANBAXY LABORATORIES LIMITED 12/3/2003- 2 76-656 FENOLDOPAM MESYLATE...
|
|
|
Prescription and OTC Drug Product List 12/1998
Prescription and Over-the-Counter Drug Product List - 18th Edition Cumulative Supplement Number 12: December 1998 [ Prescription - OTC ] ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST - ADD - ABACAVIR SULFATE ALBUTEROL SULFATE - ADD - SOLUTION; ORAL SOLUTION; INHALATION - ADD - ZIAGEN ALBUTEROL SULFATE - ADD - + GLAXO WELLCOME EQ 20MG BASE/ML N20978 001 - ADD - @ COPLEY PHARM...
|
|
|
Prescription and OTC Drug Product List 3/2000
Prescription and Over-the-Counter Drug Product List - 20th Edition Cumulative Supplement Number 3: March 2000 [ Prescription - OTC ] ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST LIST 20TH EDITION ADDITIONS/DELETIONS FOR RX DRUG PRODUCT LIST / CUMULATIVE SUPPLEMENT NUMBER 3 / JAN'2000 - MAR'2000 ACETAMINOPHEN; BUTALBITAL AMINOPHYLLINE CAPSULE; ORAL TABLET; ORAL PHRENILIN...
|
|
|
Drug Approvals for September 1997
The development of multiple follicles in the ovulatory patient participating in an Assisted Reproductive Technology (ART) program Original Application #: 020857 Approval Date: 26-SEP-97 Trade Name: COMBIVIR Chemical Type: 4 Therapeutic Potential: P Dosage Form: TABLET Applicant: GLAXO WELLCOME INC Active Ingredient(s): LAMIVUDINE; ZIDOVUDINE OTC/RX Status: RX Indication(s): Treatment...
|
|
|
Fenoldopam mesylate - LKT-F1654
- - For Pricing Information click here and submit your country
LKT-F1654 Fenoldopam mesylate [LKT] - Main Category: Dopaminergics Related Categories: - General: Product-ID LKT-F1654 Product Name Fenoldopam mesylate Product Numbers / Sizes: LKT-F1654-M025 25 mg - - LKT-F1654-M100 100 mg - - LKT-F1654-M500 500 mg - - Original Manufacturer: LKT Laboratories, Inc
Product...
|
|
|
http://www.adis.com/files/newsletters/PEN/Pncov454.pdf
Also available in a choice of flexible electronic delivery options see back cover for details 5 Jun 2004 No
Adjunctive HPV screening worth the extra cost in 5 cervical cancer Current Issues Medical education increases prescribing of Abusing elderly with overuse of drugs has to stop, osteoporosis- preventive therapy 8 says report 4 Nondrug treatment for female sexual dysfunction...
|
|
|
http://www.adis.com/files/newsletters/INP/Icov1440.pdf
17 Immunosuppressants aid recovery in erythropoietin red cell 17 ITF 1697: potential to reduce infarct size 8 aplasia Prednisone + aspirin in giant- cell arteritis 12 Rilmenidine useful for hypertension in DM 10 NEUROLOGY Saline clinically equivalent to albumin for fluid resuscitation 10 Glatiramer acetate: lack of benefit in multiple sclerosis 12 Sibutramine improves cardiovascular...
|
|
|
Pediatric Hypertensive Emergencies
– 69 Have you found Nifedipine effective 69 Any serious adverse outcomes – 6 (all were reversible Gauthier B Pediatr Nephro 97 11(6):786 Nifedipine § Still drug of choice in hypertensive urgency recommended in the most recent reviews by NEJM, Pediatrics at 0.25-0.5 mg/kg Sinaiko NEJM 1996335(26):1968 Pediatrics 1996 98(4):649 Nicardipine § CCB § Decreased...
author: Graham
|
|
|
Approved Active Moieties to which FDA has issued a Written Request for Pediatric Studies under Section 505A of the Federal
Approved Active Moieties to which FDA has issued a Written Request for Pediatric Studies under Section 505A of the Federal Food, Drug, and Cosmetic Act NOTE: This list simply identifies approved active moieties to which FDA has issued a Written Request for pediatric studies since June 1998
Desflurane Baxter Healthcare Desloratadine Schering Dichlorphenamide Merck Didanosine...
|
|
|
1998 Warning Letters and Untitled Letters to Pharmaceutical Companies
of Southern California School of Medicine DSI 2/20 6/5 4/6/99 Corlopam (fenoldopam mesylate) Injection Neurex DDMAC 2/26 4/3 Detrusitol (tolterodine tartrate) Tablets Pharmacia and Upjohn DDMAC 2/9 4/3 Inspection Ferring AB DMPQ 2/24 6/5 MetroCream (metronidazole) topical cream and MetroGel (metronidazole) Topical Gel Galderma Laboratories DDMAC 2/13 4/3 MUSE (alprostadil)...
|
|
|
2000 Warning Letters and Untitled Letters to Pharmaceutical Companies
Food and Drug Administration • Center for Drug Evaluation and Research Compliance Activities Search Warning Letters and Untitled Letters to Pharmaceutical Companies 2000 These letters, sorted by month, are supplied by the CDER Freedom of Electronic Information Office
DMPQ 10/30/2000 11/3/2000 Norco (hydrocodone bitrartrate and acetaminophen) tablets Watson Laboratories DDMAC...
|
|
|
vis_compdatasheet
a a a a a a a a a a a a a a a a a a a a a a a a a a aa a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a Catalyst/ VISUALIZER and Catalyst/ COMPARE provide the core requirements for Catalyst, an intuitive, interactive, and integrated software environment that takes you from lead generation to drug discovery...
author: byron
subject: vis_compdatasheet
duplicates:
http://www.accelrys.com/pdf/catalyst/vis_compare.pdf
|
|
|
vis_compdatasheet page 1
author: byron
subject: vis_compdatasheet
duplicates:
http://www.accelrys.com/pdf/catalyst/vis_compare.pdf
|
|
|
cat_viscomp.qxd
Provides the core tools that allow you to investigate interactive pharmacophore relationships Provides a chemistry-aware environment for modeling, visualiza- tion, 3D querying, and manual creation of pharma- cophore hypotheses Assists in managing your tasks and project data through a stockroom and lab paradigm that represents a typical chemistOs working environment a2001 Accelrys Inc...
author: Byron Konold
duplicates:
http://www.accelrys.com/pdf/catalyst/cat_viscomp_us_data.pdf
|
|
|
cat_viscomp.qxd page 1
author: Byron Konold
duplicates:
http://www.accelrys.com/pdf/catalyst/cat_viscomp_a4_data.pdf
http://www.accelrys.com/pdf/catalyst/cat_viscomp_us_data.pdf
http://www.accelrys.com/pdf/catalyst/cat_viscomp_a4_data.pdf
|
|
|
cat_viscomp.qxd
Provides the core tools that allow you to investigate interactive pharmacophore relationships Provides a chemistry-aware environment for modeling, visualiza- tion, 3D querying, and manual creation of pharma- cophore hypotheses Assists in managing your tasks and project data through a stockroom and lab paradigm that represents a typical chemistOs working environment a2001 Accelrys Inc...
author: Byron Konold
duplicates:
http://www.accelrys.com/pdf/catalyst/cat_viscomp_a4_data.pdf
|
|
|
http://www.adis.com/files/newsletters/REA/Rxcov977.pdf
20 Ergotamine: interaction with concomitant ritonavir leading to 10 Current Issues & Opinions ergotism and coma [X S] Pemetrexed: less toxicity spells savings in NSCLC 2 Fenyramidol: hepatotoxicity [ ] 10 Fewer drugs withdrawn for safety reasons in Canada than US 3 Flecainide: cardiotoxicity following in utero treatment [S] 11 Adverse Reaction Research Flecainide: fatal ventricular...
|
|
|
http://www.adis.com/files/newsletters/INP/Icov1413.pdf
3 INFECTION Cytarabine + liposomal daunorubicin in leukaemia 15 Amoxicillin/ clavulanic acid: new regimen in CAP/ sinusitis 11 Daunorubicin (liposomal) + cytarabine in leukaemia 15 Antibacterials + diagnostic strategy warranted in pneumonia 4 Dendritic cell vaccine in cutaneous T- cell lymphoma 7 Antimalarials: four most common regimens well tolerated 17 Epoetin alfa cost effective...
|
|
|
Division of Applied Pharmacology Research: Division of Applied Pharmacology Research
Food and Drug Administration • Center for Drug Evaluation and Research Office of Testing and Research Search Division of Applied Pharmacology Research Recent Publications MOD 1 Facility, Room 2021, HFD-910 8301 Muirkirk Road Laurel, MD- 20708 Phone:- (301) 594-0510-------- Fax:- (301) 594-3037 Joseph Hanig, Ph.D., Acting Director Guidance Documents and Reports Journal Articles...
author: DAPR
|
|
|
Division of Applied Pharmacology Research: Division of Applied Pharmacology Research
Food and Drug Administration • Center for Drug Evaluation and Research Office of Testing and Research Search Division of Applied Pharmacology Research Recent Publications MOD 1 Facility, Room 2021, HFD-910 8301 Muirkirk Road Laurel, MD- 20708 Phone:- (301) 594-0510-------- Fax:- (301) 594-3037 Joseph Hanig, Ph.D., Acting Director Guidance Documents and Reports Journal Articles...
author: DAPR
|
|
|
Laboratory of Clinical Pharmacology: Programs
Food and Drug Administration • Center for Drug Evaluation and Research Organizational Components Search Laboratory of Clinical Pharmacology:- Programs and Publications- Office of Pharmaceutical Science Office of Testing and Research Human Hepatotoxicity Model In Vitro Drug Metabolism and Drug-Drug Interactions PET Probes as Biomarkers for Efficacy Laboratory of Clinical...
author: Office of Testing and Research
|
|
|
Abbott to spin-off hospital products business
The new company's business will include: medication delivery systems, such as electronic drug-delivery systems, infusion therapy and critical care products; generic pharmaceuticals, including acute-care injectables and other generic anesthetics; and other businesses, including intensive care pharmaceuticals such as Precedex (dexmedetomidine HCl), Abbokinase (urokinase), and Corlopam ...
|
|
|
Hypertensive Emergencies
ENALAPRILAT: 1st IV ACE inhibitor good if CHF and low ejection fraction onset: minutes maximal effect: 30 min duration 6hrs decrease dosage in renal impairment dose= IV bolus of .625 to 1.25 mg q6h Fenoldopam: • Selective postsynaptic dopaminergic receptor (DA1) agonist with potent vasodilator and natriuretic properties • Onset=4min Duration=8-10min Dose=initial dose...
author: Dave Dyck
|
